Day One Biopharmaceuticals, Inc. (DAWN)

DAWN Revenue

Day One Biopharmaceuticals had revenue of $33.91M in the quarter ending June 30, 2025, with 313.92% growth. This brings the company's revenue in the last twelve months to $187.64M, up 2,190.50% year-over-year. In the year 2024, Day One Biopharmaceuticals had annual revenue of $131.16M.

• Revenue (ttm): $187.64M
• Revenue Growth: +2,190.50%
• P/S Ratio: 3.35
• Revenue / Employee: $1,036,674
• Employees: 181
• Market Cap: 636.10M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	131.16M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.